Regulatory News: Aelis Farma (ISIN code: FR0014007ZB4 ticker: AELIS) (Paris: AELIS), a clinical-stage biopharmaceutical company specialized in the development of treatments for brain diseases (the
Regulatory News: Aelis Farma (ISIN code: FR0014007ZB4 ticker: AELIS), a clinical-stage biopharmaceutical company specialized in the development of treatments for brain diseases (the Company »),
An exceptional fiscal year 2021, marked by positive phase 2a results for AEF0117, the recognition of the first sub-licensing revenues thanks to the signature of an industrial partnership with Indivior PLC, and securing major grants for AEF0217 (EU’s Horizon 2020 program) and AEF0117 (NIH-NIDA USA).A solid financial.
NovoBiome and Inserm form new collaboration to simulate human intestinal physiology streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.